Central IRB networks: FORM 9: Central IRB for Network Studies Form
NCI CIRB [National Cancer Institute (NCI) Central IRB for Cooperative Group Studies]
CEGIR [Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR); Cincinnati Children’s Hospital Medical Center (CCHMC) is the coordinating center and central IRB]
IRB Reliance Options for Tufts Investigators
Please note that each request for the institution to take on or give up IRB oversight for a study is carefully considered on a case-by-case basis by a group that includes the IRB Chair and Institutional Official.
SMART IRB is a Reliance Agreement that streamlines IRB review and oversight of multi-site studies. The goal of the SMART IRB agreement is to reduce duplicative IRB review by naming a single IRB of record for a research project and the institutions that will rely on that single IRB. Refer to the Tufts SMART IRB web page for more information & instruction.
Multi-site studies – SMART IRB can be used for a range of research, from large clinical trials to two-site collaborations.
This is the generic name for an agreement where Tufts Medical Center or Tufts University would rely on another IRB or another IRB would rely on Tufts.
Multi-site collaborations where the institutions have agreed to a reliance. Tufts Medical Center or Tufts University would take into consideration the level of risk associated with the research, the location, oversight, and other factors. Refer to the IRB’s IAA webpage for more information & instructions for requesting an IAA.
This is the generic name for an agreement where Tufts Medical Center or Tufts University would cover research activity of an individual investigator not associated with another IRB.
Studies where Tufts Medical Center or Tufts University agrees to cover the activity of a research team member whose institution does not have its own FWA or IRB. Refer to the IRB’s IIA webpage for more information & instructions for requesting an IIA.
Prevention and Early Treatment of Acute Lung Injury (PETAL) funded by the National Heart, Lung, and Blood Institute (NHLBI) for Acute Respiratory Distress Syndrome (ARDS); PETAL cIRB is through Vanderbilt University
Prevention and Early Treatment of Acute Lung Injury (PETAL) funded by the National Heart, Lung, and Blood Institute (NHLBI) for Acute Respiratory Distress Syndrome (ARDS). Contact the IRB Office (ext. 6-7512) for information about activating a new study through the PETAL network.